论文部分内容阅读
武汉制药(集团)股份有限公司经过六十年风雨兼程,从当年抗日根据地的一个制药所发展成今天的国有大型制药企业,拥有员工2900余名,总资产29285万元,净资产13812万元,主营医药原料、制剂的生产销售。1994年11月,武药进行了股份制改造。然而股份制改造只是给企业带来了形式上的改变,企业依旧沿袭着工厂制下的运行模式,体制上仍然制约着技术资源、人才潜能、品种优势的挖崛和发挥。面对日趋激烈的市场竞争,企业无法灵活应对,发展速度逐年下降,经济效益每况愈下,企业缺乏必要的积累,发展更是一纸空文。在这种情况下,如果不彻底更新观念,加大改革力度,加快制度创新
After 60 years of trials and hardships, Wuhan Pharmaceutical (Group) Co., Ltd. has developed into a state-owned large-scale pharmaceutical company from a pharmaceutical industry in the Anti-Japanese Base of the year. It has more than 2,900 employees, total assets of 292.85 million yuan, and net assets of 13.812 million yuan. Main production and sales of pharmaceutical raw materials and preparations. In November 1994, Wu Yao made a joint-stock reform. However, the reform of the joint-stock system only brought about a formal change to the enterprise. The company still followed the operating model under the factory system, and the system still restricted the digging and development of technical resources, talent potential, and variety advantages. In the face of increasingly fierce market competition, companies cannot cope flexibly, the development speed is declining year by year, and economic efficiency is deteriorating. Enterprises lack the necessary accumulation and development is a piece of paper. Under such circumstances, if the concept is not completely updated, reforms are intensified, and institutional innovation is accelerated.